• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤管理中的审计

Audit in the management of gliomas.

作者信息

Ayoubi S, Walter P H, Naik S, Sankaran M, Robinson D

机构信息

Department of Neurosurgery, Hurstwood Park Neurological Centre, Haywards Heath, UK.

出版信息

Br J Neurosurg. 1993;7(1):61-9. doi: 10.3109/02688699308995057.

DOI:10.3109/02688699308995057
PMID:8435147
Abstract

A retrospective study of 139 glioma patients was conducted in an effort to audit management. Factors affecting survival were studied using a Cox Proportional Hazard Model. These factors included age, sex, location, grade, type of surgery, use of radiotherapy, presenting symptoms, Karnofsky score on admission and Karnofsky score 3 months following surgery. Lower grade, high Karnofsky score on admission, radiotherapy and frontal location were associated with better survival. There was statistically insignificant evidence that the other factors had an influence on survival. Patients presenting with a poor neurological score were treated with burrhole biopsy alone. Only 10% of these patients survived more than 6 months. On the other hand, 26% of patients who had craniotomy on the basis of reasonable clinical status lived less than 6 months. Sixty-six per cent of patients in this craniotomy group were aged 60 years or over, and 66% of those aged over 60 had a Karnofsky score of less than 70. We conclude that careful judgement is required before subjecting patients aged over 60, especially those with a low Karnofsky score, to radical therapy.

摘要

对139例胶质瘤患者进行了一项回顾性研究,以审核治疗管理情况。使用Cox比例风险模型研究了影响生存的因素。这些因素包括年龄、性别、位置、分级、手术类型、放疗的使用、出现的症状、入院时的卡氏评分以及术后3个月的卡氏评分。低分级、入院时高卡氏评分、放疗和额叶位置与较好的生存相关。没有统计学意义的证据表明其他因素对生存有影响。神经学评分差的患者仅接受钻孔活检治疗。这些患者中只有10%存活超过6个月。另一方面,基于合理临床状态进行开颅手术的患者中有26%存活不到6个月。该开颅手术组中66%的患者年龄在60岁及以上,60岁以上患者中有66%的卡氏评分低于70。我们得出结论,在对60岁以上患者,尤其是卡氏评分低的患者进行根治性治疗之前,需要谨慎判断。

相似文献

1
Audit in the management of gliomas.胶质瘤管理中的审计
Br J Neurosurg. 1993;7(1):61-9. doi: 10.3109/02688699308995057.
2
Interstitial 125-iodine radiosurgery of low-grade gliomas of the insula of Reil.
Acta Neurochir (Wien). 1994;130(1-4):80-9. doi: 10.1007/BF01405506.
3
Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.恶性胶质瘤的切除术、活检及生存情况。一项关于临床参数、治疗及预后的回顾性研究。
J Neurosurg. 1993 May;78(5):767-75. doi: 10.3171/jns.1993.78.5.0767.
4
Surgery for high-grade gliomas in the aging.老年高级别胶质瘤的手术治疗。
Acta Neurol Scand. 2013 Sep;128(3):185-93. doi: 10.1111/ane.12105. Epub 2013 Feb 21.
5
Insular gliomas: the case for surgical management.岛叶胶质瘤:手术治疗的依据
J Neurosurg. 2009 Apr;110(4):685-95. doi: 10.3171/2008.7.JNS17639.
6
Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.卡莫司汀植入剂或替莫唑胺治疗基于意向治疗的高级别胶质瘤患者的预后因素和生存情况的前瞻性队列研究。
Acta Neurochir (Wien). 2012 Feb;154(2):211-22; discussion 222. doi: 10.1007/s00701-011-1199-7. Epub 2011 Oct 15.
7
Efficacy of prognostic factors on survival in patients with low grade glioma.低级别胶质瘤患者预后因素对生存的影响
Turk Neurosurg. 2008 Oct;18(4):336-44.
8
Debulking or biopsy of malignant glioma in elderly people - a randomised study.老年恶性胶质瘤的肿瘤减量手术或活检——一项随机研究
Acta Neurochir (Wien). 2003 Jan;145(1):5-10. doi: 10.1007/s00701-002-1030-6.
9
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.近期诊断的恶性胶质瘤手术后的生存率及预后因素:来自胶质瘤结局项目的数据。
J Neurosurg. 2003 Sep;99(3):467-73. doi: 10.3171/jns.2003.99.3.0467.
10
Surgery for high-grade gliomas in a developing country: survival estimation using a simple stratification system.
Surg Neurol. 2008 Dec;70(6):591-7; discussion 597. doi: 10.1016/j.surneu.2007.08.004. Epub 2008 Apr 28.

引用本文的文献

1
Brain tumor survival: results from the National Cancer Data Base.
J Neurooncol. 1998 Nov;40(2):151-60. doi: 10.1023/a:1006091608586.
2
Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis.人类恶性星形细胞瘤中10号和17号染色体短臂上的等位基因缺失及表皮生长因子受体基因扩增与预后相关。
Br J Cancer. 1994 Oct;70(4):684-9. doi: 10.1038/bjc.1994.373.